Header Logo

Connection

Debra Richardson to Sirolimus

Back to Details
This is a "connection" page, showing publications Debra Richardson has written about Sirolimus.
Debra Richardson
Connection Strength
0.044
Sirolimus
  1. Mutated p53 portends improvement in outcomes when bevacizumab is combined with chemotherapy in advanced/recurrent endometrial cancer: An NRG Oncology study. Gynecol Oncol. 2021 04; 161(1):113-121.
    View in: PubMed
    Score: 0.044
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.